OSBP-related protein 8 (ORP8) interacts with Homo sapiens sperm associated antigen 5 (SPAG5) and mediates oxysterol interference of HepG2 cell cycle

Experimental Cell Research

Volumn 322, Issue 2, 2014, Pages 227-235

  Zhong, Wenbin ^a   Zhou, You ^b   Li, Jiwei ^a   Mysore, Raghavendra ^b   Luo, Wei ^a   Li, Shiqian ^a   Chang, Mau Sun ^c   Olkkonen, Vesa M ^b   Yan, Daoguang ^a  

^a JINAN UNIVERSITY   (China)

^b MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

25 Hydroxycholesterol; Astrin; Cell cycle; ORP8; Oxysterol binding protein; SPAG5

Indexed keywords

25 HYDROXYCHOLESTEROL; ANTIGEN; BINDING PROTEIN; OXYSTEROL; OXYSTEROL BINDING PROTEIN 8; SPERM ASSOCIATED ANTIGEN 5; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL STRAIN HEPG2; CELLULAR DISTRIBUTION; CENTROMERE; COMPLEX FORMATION; ENDOPLASMIC RETICULUM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

HOMO SAPIENS;

25-HYDROXYCHOLESTEROL; ASTRIN; CELL CYCLE; ORP8; OXYSTEROL-BINDING PROTEIN; SPAG5;

BLOTTING, WESTERN; CELL CYCLE; CELL CYCLE PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HEP G2 CELLS; HUMANS; HYDROXYCHOLESTEROLS; IMMUNOPRECIPITATION; MICROSCOPY, FLUORESCENCE; RECEPTORS, STEROID; SUBCELLULAR FRACTIONS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84896039870     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.01.002     Document Type: Article

References (53)

1. Björkhem I., Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers?. Arterioscler. Thromb. Vasc. Biol. 2002, 22:734-742.
2. Javitt N.B. Oxysterols: novel biologic roles for the 21st century. Steroids 2008, 73:149-157.
3. Olkkonen V.M., Lehto M. Oxysterols and oxysterol binding proteins: role in lipid metabolism and atherosclerosis. Ann. Med. 2004, 36:562-572.
4. Lim H.K., Kang H.K., Yoo E.S., Kim B.J., Kim Y.W., Cho M., Lee J.H., Lee Y.S., Chung M.H., Hyun J.W. Oxysterols induce apoptosis and accumulation of cell cycle at G(2)/M phase in the human monocytic THP-1 cell line. Life Sci. 2003, 72:1389-1399.
5. Olkkonen V.M., Béaslas O., Nissilä E. Oxysterols and their cellular effectors. Biomolecules 2012, 2:76-103.
6. Zelcer N., Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 2006, 116:607-614.
7. Radhakrishnan A., Ikeda Y., Kwon H.J., Brown M.S., Goldstein J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. Proc. Natl. Acad. Sci. USA 2007, 104:6511-6518.
8. Wang Y., Kumar N., Crumbley C., Griffin P.R., Burris T.P. A second class of nuclear receptors for oxysterols: regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol). Biochim. Biophys. Acta 2010, 1801:917-923.
9. Wang Y., Kumar N., Solt L.A., Richardson T.I., Helvering L.M., Crumbley C., Garcia-Ordonez R.D., Stayrook K.R., Zhang X., Novick S., Chalmers M.J., Griffin P.R., Burris T.P. Modulation of retinoic acid receptor-related orphan receptor alpha and gamma activity by 7-oxygenated sterol ligands. J. Biol. Chem. 2010, 285:5013-5025.
10. Hannedouche S., Zhang J., Yi T., Shen W., Nguyen D., Pereira J.P., Guerini D., Baumgarten B.U., Roggo S., Wen B., Knochenmuss R., Noel S., Gessier F., Kelly L.M., Vanek M., Laurent S., Preuss I., Miault C., Christen I., Karuna R., Li W., Koo D.I., Suply T., Schmedt C., Peters E.C., Falchetto R., Katopodis A., Spanka C., Roy M.O., Detheux M., Chen Y.A., Schultz P.G., Cho C.Y., Seuwen K., Cyster J.G., Sailer A.W. Oxysterols direct immune cell migration via EBI2. Nature 2011, 475:524-527.
11. Liu C., Yang X.V., Wu J., Kuei C., Mani N.S., Zhang L., Yu J., Sutton S.W., Qin N., Banie H., Karlsson L., Sun S., Lovenberg T.W. Oxysterols direct B-cell migration through EBI2. Nature 2011, 475:519-523.
12. Nachtergaele S., Mydock L.K., Krishnan K., Rammohan J., Schlesinger P.H., Covey D.F., Rohatgi R. Oxysterols are allosteric activators of the oncoprotein smoothened. Nat. Chem. Biol. 2012, 8:211-220.
13. Raychaudhuri S., Prinz W.A. The diverse functions of oxysterol-binding proteins. Annu. Rev. Cell Dev. Biol. 2010, 26:157-177.
14. Ridgway N.D. Oxysterol-binding proteins. Subcell. Biochem. 2010, 51:159-182.
15. Vihervaara T., Jansen M., Uronen R.L., Ohsaki Y., Ikonen E., Olkkonen V.M. Cytoplasmic oxysterol-binding proteins: sterol sensors or transporters?. Chem. Phys. Lipids 2011, 164:443-450.
16. Tong J., Yang H., Yang H., Eom S.H., Im Y.J. Structure of osh3 reveals a conserved mode of phosphoinositide binding in oxysterol-binding proteins. Structure 2013, 21:1203-1213.
17. Maeda K., Anand K., Chiapparino A., Kumar A., Poletto M., Kaksonen M., Gavin A.-C. Interactome map uncovers phosphatidylserine transport by oxysterol-binding proteins. Nature 2013, 501:257-261.
18. Jaworski C.J., Moreira E., Li A., Lee R., Rodriguez I.R. A family of 12 human genes containing oxysterol-binding domains. Genomics 2001, 78:185-196.
19. Lehto M., Laitinen S., Chinetti G., Johansson M., Ehnholm C., Staels B., Ikonen E., Olkkonen V.M. The OSBP-related protein family in humans. J. Lipid Res. 2001, 42:1203-1213.
20. Yan D., Mäyränpää M.I., Wong J., Perttilä J., Lehto M., Jauhiainen M., Kovanen P.T., Ehnholm C., Brown A.J., Olkkonen V.M. OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages. J. Biol. Chem. 2008, 283:332-340.
21. Suchanek M., Hynynen R., Wohlfahrt G., Lehto M., Johansson M., Saarinen H., Radzikowska A., Thiele C., Olkkonen V.M. The mammalian oxysterol-binding protein-related proteins (ORPs) bind 25-hydroxycholesterol in an evolutionarily conserved pocket. Biochem. J. 2007, 405:473-480.
22. Zhou T., Li S., Zhong W., Vihervaara T., Béaslas O., Perttilä J., Luo W., Jiang Y., Lehto M., Olkkonen V.M., Yan D. OSBP-related protein 8 (ORP8) regulates plasma and liver tissue lipid levels and interacts with the nucleoporin Nup62. PLoS One 2011, 6:e21078.
23. Béaslas O., Vihervaara T., Li J., Laurila P.P., Yan D., Olkkonen V.M. Silencing of OSBP-related protein 8 (ORP8) modifies the macrophage transcriptome, nucleoporin p62 distribution, and migration capacity. Exp. Cell Res. 2012, 318:1933-1945.
24. Vihervaara T., Käkelä R., Liebisch G., Tarasov K., Schmitz G., Olkkonen V.M. Modification of the lipidome in RAW264.7 macrophage subjected to stable silencing of oxysterol-binding proteins. Biochimie 2012, 95:538-547.
25. Chang M.S., Huang C.J., Chen M.L., Chen S.T., Fan C.C., Chu J.M., Lin W.C., Yang Y.C. Cloning and characterization of hMAP126, a new member of mitotic spindle-associated proteins. Biochem. Biophys. Res. Commun. 2001, 287:116-121.
26. Mack G.J., Compton D.A. Analysis of mitotic microtubule-associated proteins using mass spectrometry identifies astrin, a spindle-associated protein. Proc. Natl. Acad. Sci. USA 2001, 98:14434-14439.
27. Cheng T.S., Hsiao Y.L., Lin C.C., Yu C.T., Hsu C.M., Chang M.S., Lee C.I., Huang C.Y., Howng S.L., Hong Y.R. Glycogen synthase kinase 3beta interacts with and phosphorylates the spindle-associated protein astrin. J. Biol. Chem. 2008, 283:2454-2464.
28. Du J., Jablonski S., Yen T.J., Hannon G.J. Astrin regulates Aurora-A localization. Biochem. Biophys. Res. Commun. 2008, 370:213-219.
29. Manning A.L., Bakhoum S.F., Maffini S., Correia-Melo C., Maiato H., Compton D.A. CLASP1, astrin and Kif2b form a molecular switch that regulates kinetochore-microtubule dynamics to promote mitotic progression and fidelity. EMBO J. 2010, 29:3531-3543.
30. Dunsch A.K., Linnane E., Barr F.A., Gruneberg U. The astrin-kinastrin/SKAP complex localizes to microtubule plus ends and facilitates chromosome alignment. J. Cell Biol. 2011, 192:959-968.
31. Schmidt J.C., Kiyomitsu T., Hori T., Backer C.B., Fukagawa T., Cheeseman I.M. Aurora B kinase controls the targeting of the Astrin-SKAP complex to bioriented kintetochores. J. Cell Biol. 2010, 1912:269-280.
32. Gruber J., Harborth J., Schnabel J., Weber K., Hatzfeld M. The mitotic-spindle-associated protein astrin is essential for progression through mitosis. J. Cell Sci. 2002, 115:4053-4059.
33. Suzuki H., Yagi M., Suzuki K. Duplicated insertion mutation in the microtubule-associated protein Spag5 (astrin/MAP126) and defective proliferation of immature Sertoli cells in rat hypogonadic (hgn/hgn) testes. Reproduction 2006, 132:79-93.
34. Javitt N.B., Javitt J.C. The retinal oxysterol pathway: a unifying hypothesis for the cause of age-related macular degeneration. Curr. Opin. Ophthalmol. 2009, 20:151-157.
35. Jeitner T.M., Voloshyna I., Reiss A.B. Oxysterol derivatives of cholesterol in neurodegenerative disorders. Curr. Med. Chem. 2011, 18:1515-1525.
36. Leoni V., Caccia C. Oxysterols as biomarkers in neurodegenerative diseases. Chem. Phys. Lipids 2011, 164:515-524.
37. Olkkonen V.M. Macrophage oxysterols and their binding proteins: roles in atherosclerosis. Curr. Opin. Lipidol. 2012, 23:462-470.
38. Shibata N., Glass C.K. Macrophages, oxysterols and atherosclerosis. Circ. J. 2010, 74:2045-2051.
39. Lordan S., Mackrill J.J., O'Brien N.M. Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases. J. Nutr. Biochem. 2009, 20:321-336.
40. Jusakul A., Yongvanit P., Loilome W., Namwat N., Kuver R. Mechanisms of oxysterol-induced carcinogenesis. Lipids Health Dis. 2011, 10:44.
41. Anticoli S., Arciello M., Mancinetti A., De Martinis M., Ginaldi L., Iuliano L., Balsano C. 7-ketocholesterol and 5,6-secosterol modulate differently the stress-activated mitogen-activated protein kinases (MAPKs) in liver cells. J. Cell Physiol. 2010, 222:586-595.
42. Velazquez E., Santos A., Montes A., Blazquez E., Ruiz-Albusac J.M. 25-Hydroxycholesterol has a dual effect on the proliferation of cultured rat astrocytes. Neuropharmacology 2006, 51:229-237.
43. Zhang X., Bai Q., Kakiyama G., Xu L., Kim J.K., Pandak W.M., Ren S. Cholesterol metabolite, 5-cholesten-3beta-25-diol-3-sulfate, promotes hepatic proliferation in mice. J. Steroid Biochem. Mol. Biol. 2012, 132:262-270.
44. Bensinger S.J., Bradley M.N., Joseph S.B., Zelcer N., Janssen E.M., Hausner M.A., Shih R., Parks J.S., Edwards P.A., Jamieson B.D., Tontonoz P. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008, 134:97-111.
45. El Roz A., Bard J.M., Huvelin J.M., Nazih H. LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis. Anticancer Res. 2012, 32:3007-3013.
46. Vedin L.L., Gustafsson J.A., Steffensen K.R. The oxysterol receptors LXRalpha and LXRbeta suppress proliferation in the colon. Molecular carcinogenesis 2012, 52:835-844.
47. English A.R., Zurek N., Voeltz G.K. Peripheral ER structure and function. Curr. Opin. Cell Biol. 2009, 21:596-602.
48. Kutay U., Hetzer M.W. Reorganization of the nuclear envelope during open mitosis. Curr. Opin. Cell Biol. 2008, 20:669-677.
49. Dasari B., Prasanthi J.R., Marwarha G., Singh B.B., Ghribi O. The oxysterol 27-hydroxycholesterol increases beta-amyloid and oxidative stress in retinal pigment epithelial cells. BMC Ophthalmol. 2010, 10:22.
50. Korade Z., Xu L., Mirnics K., Porter N.A. Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome. Journal of inherited metabolic disease 2013, 36:113-122.
51. Palozza P., Simone R., Catalano A., Boninsegna A., Bohm V., Frohlich K., Mele M.C., Monego G., Ranelletti F.O. Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J. Nutr. Biochem. 2010, 21:34-46.
52. Lorbek G., Lewinska M., Rozman D. Cytochrome P450s in the synthesis of cholesterol and bile acids-from mouse models to human diseases. FEBS J. 2012, 279:1516-1533.
53. Björkhem I. Rediscovery of cerebrosterol. Lipids 2007, 42:5-14.